Evidence map›Paper›PMID 38188676›Full record

ArticleOncology research2023

Inhibition of Ehrlich ascites carcinoma growth by melatonin: Studies with micro-CT.

Seher Yilmaz, Züleyha Doğanyiğit, Mert Ocak, Evrim Suna Arikan Söylemez, Asli Okan Oflamaz, Sümeyye Uçar, Şükrü Ateş, Ammad Ahmad Farooqi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Seher YilmazDepartment of Anatomy, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
Züleyha DoğanyiğitDepartment of Histology and Embriology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
Mert OcakDepartment of Anatomy, Faculty of Dentistry, Ankara University, Ankara, Turkey.
Evrim Suna Arikan SöylemezDepartment of Medical Biology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyon, Turkey.
Asli Okan OflamazDepartment of Histology and Embriology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
Sümeyye UçarDepartment of Anatomy, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Şükrü AteşDepartment of Anatomy, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
Ammad Ahmad FarooqiDepartment of Molecular Oncology, Institute of Biomedical and Genetic Engineering (IBGE), Islamabad, Pakistan.
Bozok Universitesi · TRAfyon Kocatepe University · TRAnkara University · TRErciyes University · TRInstitute of Biomedical and Genetic Engineering · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin is a versatile indolamine synthesized and secreted by the pineal gland in response to the photoperiodic information received by the retinohypothalamic signaling pathway. Melatonin has many benefits, such as organizing circadian rhythms and acting as a powerful hormone. We aimed to show the antitumor effects of melatonin in both

Indexed as

CarcinomaMelatoninAnimalsAscitesHumansMammalsMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesX-Ray MicrotomographyMelatoninPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAgNORApoptosisReal-time PCRSignaling pathway

Identifiers

PMID38188676
PMCPMC10767232
OpenAlexW4387917251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.